DMD Intelligence

The DMD Email Validation and Maintenance Process

Roger Korman, President

To keep your car running at peak performance, you have to maintain it properly and consistently. No one would expect a car to run well without regular tune-ups, oil changes, new tires, and so on. The same principle applies to email lists. The work a list requires is far from over once it's compiled. A quality list needs real-time authentication, domain verification, and daily updating in order to deliver the best results.

Read More
Topics: Email Marketing, Pharma Marketing, Email Campaign Design & Deployment

Crisis Management: Taking Control of Your Brand Message

Roger Korman, President

In the last part of our 6 part series, Optimizing the Pharma Brand Life Cycle At Every Phase, we examine a scenario where an unexpected market event requires an immediate distribution of information. The email channel provides pharma companies the opportunity for damage control with targeted messages, reassuring the public with case studies and clinical scientific evidence.

Read More
Topics: Pharma Marketing, AIM, Audience Identity Management

Don't Jump! A Patent Cliff Is Just Another Opportunity

Roger Korman, President
In part 5 of our 6 part series, Optimizing the Pharma Brand Life Cycle At Every Phase, we explore the use of email before a pharma product encounters the loss of exclusivity. The ability to anticipate the drop in market share allows the brand to develop a highly targeted email campaign to reach and engage key opinion leaders before the patent cliff.  
Read More
Topics: Pharma Marketing, Email Marketing, Precision Targeting

It's Not Groundhog Day: Amplifying New Indication Reach

Roger Korman, President
In part 4 of our 6 part series, Optimizing the Pharma Brand Life Cycle At Every Phase, the new indication of an existing pharma product is introduced into the marketplace via the reliable, cost efficient email channel. Unique to email is its flexible role in pharma marketing: extending the brand, reaching more HCPs, and capturing market share.
Read More
Topics: Pharma Marketing, AIM, Expanding HCP Reach

Hit The Ground Running: Optimizing Your Product Launch

Roger Korman, President
In part 3 of our 6 part series, Optimizing the Pharma Brand Life Cycle At Every Phase, we explore how to optimize the product launch, and the pivotal role that the email channel plays in supporting cross channel marketing across the span of the pharma brand’s growth and maturation process.
Read More
Topics: Pharma Marketing, Email Marketing, Email Campaign Design & Deployment

Clinical Trials: While You're Waiting, Warm Up Your Market

Roger Korman, President
In part 2 of our 6 part series, Optimizing the Pharma Brand Life Cycle At Every Phase, the clinical trial period is explored as an opportunity to prime key influencers and prescribers for the approaching launch of a pharma product. As the preferred method of communication for HCPs, the email channel is ideal to deliver educational material, case studies, trial updates and supportive evidence to brand advocates.
Read More
Topics: Pharma Marketing, Email Marketing, Precision Targeting

Market Development: Begin To Tell Your Product Story

Roger Korman, President
In part 1 of our 6 part series, Optimizing the Pharma Brand Life Cycle At Every Phase, we examine the pharma product in market development; leveraging the email channel to communicate with key opinion leaders is critical to the success of the brand manager.
Read More
Topics: Pharma Marketing, Email Marketing, Precision Targeting, Email Campaign Design & Deployment

6 Email Marketing Tactics to Drive ROI

Roger Korman, President

A major email marketing campaign can easily cost six figures or more. With that kind of investment at stake, you want to make sure you get the most bang for your buck. These six straightforward tactics will help you drastically improve the ROI of your physician email campaigns.

Read More
Topics: Email Marketing

Responsive Design and the Email Marketing Landscape

Roger Korman, President

Just when you thought you had mastered the world of mobile email compatibility, that world is upended by new mobile technology. Email marketers already had to weather the jarring transition from desktop to mobile, but now they must keep up with constant mobile innovations to stay even remotely relevant. According to an Experian survey, 53 percent of all emails were opened on a mobile device in the third quarter of 2014.

Read More
Topics: Email Campaign Design & Deployment, Email Marketing, Pharma Marketing

Subscribe to Email Updates

About the Blog

DMD President Roger Korman and his management team publish weekly articles on digital communication and technology in healthcare.

Articles are published that cover website visitor identity, the value of authenticated healthcare professional databases for use in multichannel marketing to physicians and healthcare professionals. DMD clients in pharma, hospital and health systems, agencies, and physician marketing companies rely on DMD's email and AIMSM technologies to improve communication with healthcare professionals across marketing channels.